Pushing the Boundaries: Advancing Bladder Cancer Diagnosis through the Integration of Detection and Precision Medicine

Dear Colleagues,

Bladder cancer diagnosis has undergone substantial advancements through the integration of molecular detection and imaging methods. Imaging plays a pivotal role in visualizing and discerning abnormalities within the body, offering a non-invasive avenue for tumor detection, size assessment, precise localization, and the provision of comprehensive anatomical and functional insights into cancer. On the molecular front, innovative detection technologies have transformed bladder cancer diagnosis, enabling the identification of specific biomarkers associated with distinct types of the condition. Molecular detection methods facilitate early detection, tumor characterization, and treatment response monitoring, paving the way for personalized and targeted therapeutic strategies. The collaboration between imaging and molecular detection improves the accuracy of cancer diagnosis and deepens our understanding of the biological processes that propel cancer progression. This integrated approach holds significant promise in advancing patient outcomes through early detection, meticulous treatment planning, and the monitoring of therapeutic responses, ultimately progressing bladder cancer management and research.

Dr. Vadanasundari Vedarethinam
Prof. Dr. Merce Jorda
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Diagnostics is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

• bladder cancer
• blood analysis
• biomarkers
• benetic biomarkers
• CT, MRI, PET, and SPECT
• personalized medicine
• prognostic diagnostics